Medicine and Dentistry
Patient
100%
Airflow
58%
Plasma
58%
Lung
55%
Therapeutic Procedure
54%
Calreticulin
52%
Atypical Mycobacterium
52%
Lung Cancer
46%
Culture
43%
Visceral Pleura
41%
Woman
41%
Immune Checkpoint Inhibitor
41%
Spirometry
39%
Diagnosis
37%
Thoracoscopy
34%
Prevalence
33%
Deterioration
31%
Prognosis
31%
Pulmonary Sequestration
29%
Mycetoma
29%
Abemaciclib
29%
Chemotherapy
29%
Paragonimiasis
29%
Chronic Myelomonocytic Leukemia
29%
Pleurisy
29%
Tezepelumab
29%
Spontaneous Pneumothorax
29%
Lymphocytic Interstitial Pneumonia
29%
Retrospective Cohort Study
29%
COVID-19
29%
Pollen Allergy
29%
Hospital
23%
Chronic Obstructive Pulmonary Disease
23%
Specimen
22%
Tongue
22%
Inpatient
20%
Combination Therapy
20%
Association
19%
Receptor Gene
19%
Surgery
19%
Epidermal Growth Factor Receptor
19%
Lung Aspergillosis
19%
Tuberculosis
19%
Infection
19%
Observational Study
17%
Cancer Treatment
17%
Non Small Cell Lung Cancer
17%
Paracetamol
17%
Granuloma
17%
Epithelioid Cell
17%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
58%
Disease
29%
Sulfasalazine
29%
Mepolizumab
29%
Loeffler Pneumonia
29%
Abemaciclib
29%
Chronic Myelomonocytic Leukemia
29%
Tezepelumab
29%
Hemoptysis
29%
Coronavirinae
29%
Asthma
29%
Hemoptysis
29%
Mycobacterium Avium Complex
29%
Sleep Disordered Breathing
29%
Calreticulin
23%
Epidermal Growth Factor Receptor
19%
Malignant Neoplasm
18%
Non Small Cell Lung Cancer
18%
Lung Cancer
17%
Blast Cell Crisis
14%
Goserelin
11%
Letrozole
11%
Lipocortin 1
11%
Heat Shock Protein 70
11%
Agranulocytosis
9%
Immunogenic Cell Death
9%
Methylprednisolone
9%
Fibrosis
9%
Lung Disease
8%
Progression Free Survival
8%
Toxicity
8%
Cisplatin
8%
Pemetrexed
8%
Fluticasone Furoate Plus Umeclidinium Plus Vilanterol
7%
Ethinylestradiol Plus Megestrol Acetate
5%
Platinum
5%
Histone H3
5%
Biochemistry, Genetics and Molecular Biology
Calreticulin
52%
Blood Level
41%
High-Mobility Group
34%
Cohort Study
33%
Mycobacterium Avium Complex
29%
Antibody Blood Level
29%
Atypical Mycobacterium
29%
Cell Death
21%
Heat Shock Protein
16%
Annexin A1
16%
Progression Free Survival
14%
Association
13%
Overall Survival
11%
Kinetics
11%
Electric Potential
11%
Survival Rate
6%
All Cause Mortality
6%
Time
5%
Histone H3
5%
Cancer Cell
5%